Status and phase
Conditions
Treatments
Study type
Funder types
Identifiers
About
The ALSpire Study is a clinical trial evaluating the investigational drug BIIB105 in adults living with amyotrophic lateral sclerosis (ALS).
The ALSpire Study consists of two parts:
The objectives of the study are to evaluate:
Full description
About BIIB105:
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key Inclusion Criteria:
Part 1:
Part 2:
Key Exclusion Criteria
Part 1:
Part 2:
NOTE: Other protocol defined Inclusion/Exclusion criteria may apply.
Primary purpose
Allocation
Interventional model
Masking
99 participants in 9 patient groups, including a placebo group
Loading...
Central trial contact
US Biogen Clinical Trial Center; Global Biogen Clinical Trial Center
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal